SELB Selecta Biosciences Inc gains 17% Nov 6, 2020

Posted By: Rajesh Srivastava - Friday, November 06, 2020

Share

& Comment

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.http://www.priceseries.com/trade/SELB-Selecta-Biosciences-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020102120201106.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.